Bonjour, ceci est un commentaire. Pour supprimer un commentaire, connectez-vous et affichez les commentaires de cet article. Vous pourrez alors…
N. A. Cridland, “Electromagnetic Fields and Cancer: A Review of Relevant Cellular Studies,” Chilton, National Radiological Protection Board, London, 1993.
- Listed: 30 May 2026 0 h 29 min
Description
N. A. Cridland, “Electromagnetic Fields and Cancer: A Review of Relevant Cellular Studies,” Chilton, National Radiological Protection Board, London, 1993.
**N. A. Cridland, “Electromagnetic Fields and Cancer: A Review of Relevant Cellular Studies,” Chilton, National Radiological Protection Board, London, 1993.**
*Understanding the legacy of a pivotal 1993 review and its relevance to today’s electromagnetic‑field (EMF) safety debate.*
—
When the National Radiological Protection Board (NRPB) released N. A. Cridland’s comprehensive 1993 review, “Electromagnetic Fields and Cancer: A Review of Relevant Cellular Studies,” it marked a watershed moment for scientists, policymakers, and the public. The report synthesized decades of laboratory work, aiming to answer a pressing question: **Do electromagnetic fields (EMFs) contribute to cancer development at the cellular level?**
### The scientific landscape of the early 1990s
In the late‑20th century, the rapid expansion of telecommunications, power‑line infrastructure, and household appliances sparked growing concern about chronic exposure to low‑frequency (ELF) and radio‑frequency (RF) fields. Researchers were divided—some studies hinted at DNA damage or altered cell proliferation, while others found no measurable effect. Cridland’s review served as a neutral, evidence‑based bridge, meticulously cataloguing **in‑vitro cellular experiments**, **dose‑response relationships**, and **methodological strengths and weaknesses**.
Key findings from the 1993 document included:
1. **Limited evidence of direct DNA strand breaks** under typical environmental EMF intensities.
2. **Inconsistent reports of altered cell cycle progression**, often linked to experimental artifacts such as temperature fluctuations.
3. **No reproducible increase in tumorigenic transformation** in cultured fibroblasts or lymphocytes at exposure levels below international safety limits.
These conclusions reinforced the prevailing view that **ordinary EMF exposure is unlikely to be a carcinogenic factor**, a stance later echoed by the International Agency for Research on Cancer (IARC) and the World Health Organization (WHO).
### Why the review still matters today
Fast forward three decades, and the conversation has evolved but not disappeared. Modern concerns now focus on **5G millimeter‑wave technology**, **wearable devices**, and **smart home ecosystems**—all of which operate at higher frequencies than the ELF fields examined in Cridland’s era. Yet the **methodological framework** established in the 1993 review remains a gold standard:
– **Rigorous control of temperature and sham exposure** to isolate EMF effects.
– **Standardized dosimetry** to ensure reproducible field strengths across laboratories.
– **Transparent reporting of statistical analysis**, reducing the risk of false‑positive findings.
Researchers designing contemporary cellular studies still cite Cridland’s criteria when justifying experimental design, underscoring the review’s lasting impact on **radiation safety standards** and **public health policy**.
### Bridging past research with future investigations
The quote itself—an academic citation—may appear dry, but it encapsulates a pivotal moment when the scientific community collectively demanded **high‑quality evidence** before drawing health conclusions. Today’s investigators can build on that foundation by:
– **Employing advanced imaging** (e.g., live‑cell fluorescence microscopy) to detect subtle subcellular changes.
– **Integrating omics technologies** (genomics, proteomics) to capture global cellular responses to EMF exposure.
– **Conducting long‑term, low‑dose studies** that mirror real‑world exposure scenarios, something early 1990s studies could not fully achieve.
### Practical takeaways for readers
1. **Current EMF safety guidelines** are largely based on the weight of evidence that began with reviews like Cridland’s.
2. **No conclusive link** between everyday EMF exposure and cancer has emerged from robust cellular research.
3. **Continued vigilance** is essential—new frequencies and exposure patterns require fresh, well‑controlled experiments.
### SEO‑friendly keywords
Electromagnetic fields, EMF cancer research, cellular studies, NRPB review, N. A. Cridland, radiation safety, low‑frequency fields, radio‑frequency exposure, 1993 cancer review, DNA damage, 5G health effects, scientific methodology, public health policy, environmental health, cancer risk assessment.
—
By revisiting Cridland’s 1993 review, we not only honor a milestone in **electromagnetic field safety research** but also remind ourselves that **rigorous science**—rooted in transparent methodology and reproducible results—remains the cornerstone of informed health decisions. Whether you’re a researcher, policy maker, or curious citizen, understanding the legacy of this seminal work helps navigate the complex, ever‑evolving landscape of EMF and cancer research.
5 total views, 1 today
Sponsored Links
T. Uno, N. Yasui-Furukori, T. Takahata, K. Sugawara and T. Tateishi, “Deter...
T. Uno, N. Yasui-Furukori, T. Takahata, K. Sugawara and T. Tateishi, “Determination of Lansoprazole and Two of its Metabolites by Liquid-Liquid Extraction and Automated Column […]
2 total views, 2 today
“The United States Pharmacopoeia,” 27th Edition, “Na-tional Formulary 22,” ...
“The United States Pharmacopoeia,” 27th Edition, “Na-tional Formulary 22,” Asian Edition, Rockville, 2004. **“The United States Pharmacopoeia,” 27th Edition, “Na‑tional Formulary 22,” Asian Edition, Rockville, 2004.** […]
2 total views, 2 today
J. M. Ritter, L. D. Lewis and T. G. K. Mant, “A Textbook of Clinical Pharma...
J. M. Ritter, L. D. Lewis and T. G. K. Mant, “A Textbook of Clinical Pharmacology,” 4th Edition, Arnold Ltd., London, 1999. **J. M. Ritter, […]
3 total views, 3 today
Y. Y. Chan, Y. L. Leu and T. S. Wu, “The Constituents of the Leaves of Aris...
Y. Y. Chan, Y. L. Leu and T. S. Wu, “The Constituents of the Leaves of Aristolochia heterophylla Hemsl.,” Chemical and Pharmaceutical Bulletin, Vol. 47, […]
2 total views, 2 today
L. Ma and D. J. Dolphin, “Stereoselective Synthesis of New Chlorophyll a Re...
L. Ma and D. J. Dolphin, “Stereoselective Synthesis of New Chlorophyll a Related Antioxidants Isolated from Marine Organisms,” Journal of Organic Chemistry, Vol. 61, No. […]
2 total views, 2 today
M. S. Buchanane, T. Hashimoto and Y. Asakawa, “Phytyl Esters and Phaeophyti...
M. S. Buchanane, T. Hashimoto and Y. Asakawa, “Phytyl Esters and Phaeophytins from the Hornwort Megaceros flagellaris,” Phytochemistry, Vol. 41, No. 5, March 1996, pp. […]
1 total views, 1 today
M. C. Rho, M. Y. Chung, H. Y. Song, O. E. Kwon, S. W. Lee, J. A. Baek, K. H...
M. C. Rho, M. Y. Chung, H. Y. Song, O. E. Kwon, S. W. Lee, J. A. Baek, K. H. Jeune, K. Kim, H. S. […]
2 total views, 2 today
W. T. Li, H. W. Tsao, Y. Y. Chen, S. W. Cheng and Y. C. Hsu, “A Study on th...
W. T. Li, H. W. Tsao, Y. Y. Chen, S. W. Cheng and Y. C. Hsu, “A Study on the Photodynamic Properties of Chlo-rophyll Derivatives […]
3 total views, 3 today
X. H. Yang, H. B. Lee, H. Chen, P. Li and B. P. Ye, “Chemical Constituents ...
X. H. Yang, H. B. Lee, H. Chen, P. Li and B. P. Ye, “Chemical Constituents in the Leave of Rhizophora stylosa L and their […]
3 total views, 3 today
H. K. Wang and K. H. Lee, “Plant-Derived Anticancer Agents and their Analog...
H. K. Wang and K. H. Lee, “Plant-Derived Anticancer Agents and their Analogs Currently in Clinical Use or in Clinical Trials,” Botanical Bulletin of Academia […]
3 total views, 3 today
T. Uno, N. Yasui-Furukori, T. Takahata, K. Sugawara and T. Tateishi, “Deter...
T. Uno, N. Yasui-Furukori, T. Takahata, K. Sugawara and T. Tateishi, “Determination of Lansoprazole and Two of its Metabolites by Liquid-Liquid Extraction and Automated Column […]
2 total views, 2 today
“The United States Pharmacopoeia,” 27th Edition, “Na-tional Formulary 22,” ...
“The United States Pharmacopoeia,” 27th Edition, “Na-tional Formulary 22,” Asian Edition, Rockville, 2004. **“The United States Pharmacopoeia,” 27th Edition, “Na‑tional Formulary 22,” Asian Edition, Rockville, 2004.** […]
2 total views, 2 today
J. M. Ritter, L. D. Lewis and T. G. K. Mant, “A Textbook of Clinical Pharma...
J. M. Ritter, L. D. Lewis and T. G. K. Mant, “A Textbook of Clinical Pharmacology,” 4th Edition, Arnold Ltd., London, 1999. **J. M. Ritter, […]
3 total views, 3 today
Y. Y. Chan, Y. L. Leu and T. S. Wu, “The Constituents of the Leaves of Aris...
Y. Y. Chan, Y. L. Leu and T. S. Wu, “The Constituents of the Leaves of Aristolochia heterophylla Hemsl.,” Chemical and Pharmaceutical Bulletin, Vol. 47, […]
2 total views, 2 today
L. Ma and D. J. Dolphin, “Stereoselective Synthesis of New Chlorophyll a Re...
L. Ma and D. J. Dolphin, “Stereoselective Synthesis of New Chlorophyll a Related Antioxidants Isolated from Marine Organisms,” Journal of Organic Chemistry, Vol. 61, No. […]
2 total views, 2 today
M. S. Buchanane, T. Hashimoto and Y. Asakawa, “Phytyl Esters and Phaeophyti...
M. S. Buchanane, T. Hashimoto and Y. Asakawa, “Phytyl Esters and Phaeophytins from the Hornwort Megaceros flagellaris,” Phytochemistry, Vol. 41, No. 5, March 1996, pp. […]
1 total views, 1 today
M. C. Rho, M. Y. Chung, H. Y. Song, O. E. Kwon, S. W. Lee, J. A. Baek, K. H...
M. C. Rho, M. Y. Chung, H. Y. Song, O. E. Kwon, S. W. Lee, J. A. Baek, K. H. Jeune, K. Kim, H. S. […]
2 total views, 2 today
W. T. Li, H. W. Tsao, Y. Y. Chen, S. W. Cheng and Y. C. Hsu, “A Study on th...
W. T. Li, H. W. Tsao, Y. Y. Chen, S. W. Cheng and Y. C. Hsu, “A Study on the Photodynamic Properties of Chlo-rophyll Derivatives […]
3 total views, 3 today
X. H. Yang, H. B. Lee, H. Chen, P. Li and B. P. Ye, “Chemical Constituents ...
X. H. Yang, H. B. Lee, H. Chen, P. Li and B. P. Ye, “Chemical Constituents in the Leave of Rhizophora stylosa L and their […]
3 total views, 3 today
H. K. Wang and K. H. Lee, “Plant-Derived Anticancer Agents and their Analog...
H. K. Wang and K. H. Lee, “Plant-Derived Anticancer Agents and their Analogs Currently in Clinical Use or in Clinical Trials,” Botanical Bulletin of Academia […]
3 total views, 3 today
Recent Comments